Menora Mivtachim Holdings’s Elevance Health ELV Stock Holding History

Menora Mivtachim Holdings’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-150,360	Closed	-$43.1M	–	75
2019 Q1	$43.1M	Sell	150,360 -50,465	-25%	-$14.6M	1.16%	39
2018 Q4	$52.7M	Buy	200,825 +1,010	+0.5%	+$278K	1.52%	28
2018 Q3	$54.8M	Buy	199,815 +51,800	+35%	+$13.4M	1.48%	21
2018 Q2	$35.2M	Hold	148,015	–	–	1%	36
2018 Q1	$32.5M	Hold	148,015	–	–	1.03%	32
2017 Q4	$33.3M	Hold	148,015	–	–	1.29%	33
2017 Q3	$28.1M	Buy	148,015 +1,015	+0.7%	+$193K	1.14%	35
2017 Q2	$27.7M	Buy	+147,000	New	+$26.4M	1.29%	34

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Menora Mivtachim Holdings's ELV Position: Q2 2019 in Review

Menora Mivtachim Holdings sold out of Elevance Health (ELV) in Q2 2019, closing a stake of 150,360 shares — an estimated $43.1M sold.

Menora Mivtachim Holdings first reported a position in ELV in Q2 2017 and held it in 8 quarters. The position peaked at $54.8M in Q3 2018. 1,030 funds tracked by Wall St. Rank hold ELV as of Q2 2019.

Menora Mivtachim Holdings reported no remaining Elevance Health position as of Q2 2019 after selling out during the quarter.
Menora Mivtachim Holdings sold 150,360 Elevance Health shares in Q2 2019, an estimated $43.1M.
Menora Mivtachim Holdings first reported a position in Elevance Health in Q2 2017 and held it in 8 quarters.
Menora Mivtachim Holdings's Elevance Health position peaked at $54.8M in Q3 2018.
1,030 funds tracked by Wall St. Rank held Elevance Health as of Q2 2019.

Based on Menora Mivtachim Holdings's 13F filing for Q2 2019, filed 1 Aug 2019.